- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 801KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 143KB)
Risperidone – March 2024
Risperidone: I.M. injection (modified release), set containing 1 pre filled syringe powder for injection 75 mg and 1 pre filled syringe diluent 383 microlitres, I.M. injection (modified release), set containing 1 pre filled syringe powder for injection 100 mg and 1 pre filled syringe diluent 490 microlitres; Okedi®
Last updated
30 May 2025
